Identification of cathepsin B as a novel target of hypoxia-inducible factor-1-alpha in HepG2 cells

Hypoxia-inducible factor-1-alpha (HIF-1α) activates the transcription of many genes that code for proteins involved in angiogenesis, glucose metabolism, cell proliferation/survival, and invasion/metastasis. However, the mechanisms between HIF-1 and its downstream target genes are still poorly unders...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 503; no. 2; pp. 1057 - 1062
Main Authors Xiaofei, Cheng, Yanqing, Li, Dongkai, Zhou, Dong, Chen, Feng, Zhao, Weilin, Wang
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 05.09.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hypoxia-inducible factor-1-alpha (HIF-1α) activates the transcription of many genes that code for proteins involved in angiogenesis, glucose metabolism, cell proliferation/survival, and invasion/metastasis. However, the mechanisms between HIF-1 and its downstream target genes are still poorly understood. Our experimental results had shown that nuclear HIF-1α proteins were significantly induced after HepG2 cells treatment with 1% O2 for 6 h and reached the peak expression level in 24 h. Meanwhile, the results of RT-qPCR and Western-blotting showed that HIF-1α and cathepsin B (CTSB) expressions increased with a similar pattern in response to hypoxia in the HepG2 cells. Additionally, based on bioinformatics analysis, we identified a hypoxia response element in the CTSB promoter, indicating a possible association between HIF-1α and CTSB. Moreover, luciferase assay was performed to reflect the transcriptional activity mediated through the HIF-1α binding HRE within the CTSB promoter. Furthermore, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (CHIP) revealed a specific HIF-1α binding activity to the CTSB gene promoter. For the first time, we demonstrated that CTSB is a new HIF-1α-target gene. We believe these findings will contribute to the research and development of neoplasm-targeted therapies. •Cathepsin B (CTSB) is a novel target gene of hypoxia-inducible factor-1-alpha (HIF-1α).•CTSB mRNA and protein levels can be up-regulated in a HIF-1α-dependent manner.•CTSB promoter activity can be elevated by the HIF-1α protein.•HIF-1α protein binds the CTSB promoter directly.
AbstractList Hypoxia-inducible factor-1-alpha (HIF-1α) activates the transcription of many genes that code for proteins involved in angiogenesis, glucose metabolism, cell proliferation/survival, and invasion/metastasis. However, the mechanisms between HIF-1 and its downstream target genes are still poorly understood. Our experimental results had shown that nuclear HIF-1α proteins were significantly induced after HepG2 cells treatment with 1% O2 for 6 h and reached the peak expression level in 24 h. Meanwhile, the results of RT-qPCR and Western-blotting showed that HIF-1α and cathepsin B (CTSB) expressions increased with a similar pattern in response to hypoxia in the HepG2 cells. Additionally, based on bioinformatics analysis, we identified a hypoxia response element in the CTSB promoter, indicating a possible association between HIF-1α and CTSB. Moreover, luciferase assay was performed to reflect the transcriptional activity mediated through the HIF-1α binding HRE within the CTSB promoter. Furthermore, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (CHIP) revealed a specific HIF-1α binding activity to the CTSB gene promoter. For the first time, we demonstrated that CTSB is a new HIF-1α-target gene. We believe these findings will contribute to the research and development of neoplasm-targeted therapies. •Cathepsin B (CTSB) is a novel target gene of hypoxia-inducible factor-1-alpha (HIF-1α).•CTSB mRNA and protein levels can be up-regulated in a HIF-1α-dependent manner.•CTSB promoter activity can be elevated by the HIF-1α protein.•HIF-1α protein binds the CTSB promoter directly.
Hypoxia-inducible factor-1-alpha (HIF-1α) activates the transcription of many genes that code for proteins involved in angiogenesis, glucose metabolism, cell proliferation/survival, and invasion/metastasis. However, the mechanisms between HIF-1 and its downstream target genes are still poorly understood. Our experimental results had shown that nuclear HIF-1α proteins were significantly induced after HepG2 cells treatment with 1% O2 for 6 h and reached the peak expression level in 24 h. Meanwhile, the results of RT-qPCR and Western-blotting showed that HIF-1α and cathepsin B (CTSB) expressions increased with a similar pattern in response to hypoxia in the HepG2 cells. Additionally, based on bioinformatics analysis, we identified a hypoxia response element in the CTSB promoter, indicating a possible association between HIF-1α and CTSB. Moreover, luciferase assay was performed to reflect the transcriptional activity mediated through the HIF-1α binding HRE within the CTSB promoter. Furthermore, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (CHIP) revealed a specific HIF-1α binding activity to the CTSB gene promoter. For the first time, we demonstrated that CTSB is a new HIF-1α-target gene. We believe these findings will contribute to the research and development of neoplasm-targeted therapies.
Hypoxia-inducible factor-1-alpha (HIF-1α) activates the transcription of many genes that code for proteins involved in angiogenesis, glucose metabolism, cell proliferation/survival, and invasion/metastasis. However, the mechanisms between HIF-1 and its downstream target genes are still poorly understood. Our experimental results had shown that nuclear HIF-1α proteins were significantly induced after HepG2 cells treatment with 1% O for 6 h and reached the peak expression level in 24 h. Meanwhile, the results of RT-qPCR and Western-blotting showed that HIF-1α and cathepsin B (CTSB) expressions increased with a similar pattern in response to hypoxia in the HepG2 cells. Additionally, based on bioinformatics analysis, we identified a hypoxia response element in the CTSB promoter, indicating a possible association between HIF-1α and CTSB. Moreover, luciferase assay was performed to reflect the transcriptional activity mediated through the HIF-1α binding HRE within the CTSB promoter. Furthermore, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (CHIP) revealed a specific HIF-1α binding activity to the CTSB gene promoter. For the first time, we demonstrated that CTSB is a new HIF-1α-target gene. We believe these findings will contribute to the research and development of neoplasm-targeted therapies.
Highlights: • Cathepsin B (CTSB) is a novel target gene of hypoxia-inducible factor-1-alpha (HIF-1α). • CTSB mRNA and protein levels can be up-regulated in a HIF-1α-dependent manner. • CTSB promoter activity can be elevated by the HIF-1α protein. • HIF-1α protein binds the CTSB promoter directly. Hypoxia-inducible factor-1-alpha (HIF-1α) activates the transcription of many genes that code for proteins involved in angiogenesis, glucose metabolism, cell proliferation/survival, and invasion/metastasis. However, the mechanisms between HIF-1 and its downstream target genes are still poorly understood. Our experimental results had shown that nuclear HIF-1α proteins were significantly induced after HepG2 cells treatment with 1% O{sub 2} for 6 h and reached the peak expression level in 24 h. Meanwhile, the results of RT-qPCR and Western-blotting showed that HIF-1α and cathepsin B (CTSB) expressions increased with a similar pattern in response to hypoxia in the HepG2 cells. Additionally, based on bioinformatics analysis, we identified a hypoxia response element in the CTSB promoter, indicating a possible association between HIF-1α and CTSB. Moreover, luciferase assay was performed to reflect the transcriptional activity mediated through the HIF-1α binding HRE within the CTSB promoter. Furthermore, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (CHIP) revealed a specific HIF-1α binding activity to the CTSB gene promoter. For the first time, we demonstrated that CTSB is a new HIF-1α-target gene. We believe these findings will contribute to the research and development of neoplasm-targeted therapies.
Author Feng, Zhao
Xiaofei, Cheng
Dongkai, Zhou
Yanqing, Li
Dong, Chen
Weilin, Wang
Author_xml – sequence: 1
  givenname: Cheng
  surname: Xiaofei
  fullname: Xiaofei, Cheng
  organization: Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China
– sequence: 2
  givenname: Li
  surname: Yanqing
  fullname: Yanqing, Li
  organization: Department of Pathology, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
– sequence: 3
  givenname: Zhou
  orcidid: 0000-0003-0705-9796
  surname: Dongkai
  fullname: Dongkai, Zhou
  organization: Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
– sequence: 4
  givenname: Chen
  surname: Dong
  fullname: Dong, Chen
  organization: Department of Colorectal Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China
– sequence: 5
  givenname: Zhao
  surname: Feng
  fullname: Feng, Zhao
  organization: Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
– sequence: 6
  givenname: Wang
  surname: Weilin
  fullname: Weilin, Wang
  email: wam@zju.edu.cn
  organization: Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29935187$$D View this record in MEDLINE/PubMed
https://www.osti.gov/biblio/23105634$$D View this record in Osti.gov
BookMark eNp9kU9v1DAQxS1URLeFL8ABReLCJcuMHTuJxAWq_pMqcQGJm2U7E9arrB1sb0W_PYm2cOQ0c_i9p6f3LthZiIEYe4uwRUD1cb-1NrktB-y2oLaI6gXbIPRQc4TmjG0AQNW8xx_n7CLnPQBio_pX7Jz3vZDYtRtm7wcKxY_emeJjqOJYLd-O5uxD9aUyuTJViI80VcWkn1RWYPc0x9_e1D4MR-ftRNVoXImpxtpM885Ui_SO5lteOZqm_Jq9HM2U6c3zvWTfb66_Xd3VD19v768-P9SukX2psZVkGtF0Vo5cDVwKzjtjiZtBjE3L0QihpBwEohVgu3ZoAGXXtVYZkK0Ql-z9yTfm4nV2vpDbuRgCuaK5QJBKNAv14UTNKf46Ui764POa0wSKx6w5yE5Cq9RqyE-oSzHnRKOekz-Y9KQR9LqA3ut1Ab0uoEHpZYFF9O7Z_2gPNPyT_K18AT6dAFq6ePSU1qgUHA0-rUmH6P_n_weu_pZv
CitedBy_id crossref_primary_10_1016_j_jconrel_2020_11_040
crossref_primary_10_1172_JCI166954
crossref_primary_10_1002_jev2_12310
crossref_primary_10_1016_j_canlet_2018_08_029
crossref_primary_10_1111_jfb_15399
crossref_primary_10_3390_ijms22168596
crossref_primary_10_1021_jacsau_4c00298
crossref_primary_10_3389_fphar_2020_621054
crossref_primary_10_3389_fimmu_2019_02037
crossref_primary_10_1134_S1990519X22020079
crossref_primary_10_1093_abbs_gmz105
crossref_primary_10_3389_fcell_2023_1236271
crossref_primary_10_1002_path_6076
crossref_primary_10_1016_j_canlet_2019_02_035
crossref_primary_10_3389_fonc_2022_925379
crossref_primary_10_1038_s41598_024_65537_9
Cites_doi 10.1016/j.bbrc.2010.08.108
10.1182/blood-2004-07-2958
10.1016/S0092-8674(01)00507-4
10.1016/j.bbrc.2005.08.165
10.1038/nrc1187
10.1126/science.aaf4405
10.1002/med.21477
10.4155/fmc.14.73
10.1093/emboj/17.22.6573
10.1186/s12943-016-0503-9
10.1038/emm.2004.1
10.1097/00000441-199307000-00010
10.1016/S1535-6108(04)00117-5
10.1002/prca.201300105
10.1016/j.pharmthera.2016.04.009
ContentType Journal Article
Copyright 2018 Elsevier Inc.
Copyright © 2018 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2018 Elsevier Inc.
– notice: Copyright © 2018 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
OTOTI
DOI 10.1016/j.bbrc.2018.06.116
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
OSTI.GOV
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
Biology
EISSN 1090-2104
EndPage 1062
ExternalDocumentID 23105634
10_1016_j_bbrc_2018_06_116
29935187
S0006291X18314281
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-~X
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAXUO
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABYKQ
ACDAQ
ACGFO
ACGFS
ACNCT
ACRLP
ADBBV
ADEZE
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
CS3
D0L
DM4
DOVZS
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
K-O
KOM
L7B
LG5
LX2
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RIG
RNS
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSU
SSZ
T5K
TWZ
WH7
XPP
XSW
ZA5
ZMT
~02
~G-
AAHBH
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
.55
.GJ
.HR
1CY
3O-
9M8
AAQXK
AAYJJ
AAYXX
ABEFU
ABXDB
ACKIV
ADFGL
ADIYS
ADMUD
AFJKZ
AGRDE
AHHHB
ASPBG
AVWKF
AZFZN
CAG
CITATION
COF
FEDTE
FGOYB
G-2
G8K
HLW
HVGLF
HZ~
MVM
OHT
R2-
SBG
SEW
UQL
WUQ
X7M
Y6R
ZGI
ZKB
~KM
7X8
AALMO
AAPBV
ABPIF
ABQIS
EFJIC
OTOTI
ID FETCH-LOGICAL-c459t-175ea4348b5f26d253228abe2ad3f4721a33655d311b30b87d4015887b6a05733
IEDL.DBID AIKHN
ISSN 0006-291X
IngestDate Fri May 19 00:40:23 EDT 2023
Fri Aug 16 02:04:13 EDT 2024
Thu Sep 26 19:12:50 EDT 2024
Sat Sep 28 08:40:03 EDT 2024
Fri Feb 23 02:49:48 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Cathepsin B (CTSB)
Transcription
Hypoxia-inducible factor-1-alpha (HIF-1α)
Target gene
Language English
License Copyright © 2018 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c459t-175ea4348b5f26d253228abe2ad3f4721a33655d311b30b87d4015887b6a05733
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0705-9796
PMID 29935187
PQID 2058507663
PQPubID 23479
PageCount 6
ParticipantIDs osti_scitechconnect_23105634
proquest_miscellaneous_2058507663
crossref_primary_10_1016_j_bbrc_2018_06_116
pubmed_primary_29935187
elsevier_sciencedirect_doi_10_1016_j_bbrc_2018_06_116
PublicationCentury 2000
PublicationDate 2018-09-05
PublicationDateYYYYMMDD 2018-09-05
PublicationDate_xml – month: 09
  year: 2018
  text: 2018-09-05
  day: 05
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Biochemical and biophysical research communications
PublicationTitleAlternate Biochem Biophys Res Commun
PublicationYear 2018
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Krishnamachary, Berg-Dixon, Kelly, Agani, Feldser, Ferreira, Iyer, LaRusch, Pak, Taghavi, Semenza (bib6) 2003; 63
Kallio, Okamoto, O'Brien, Carrero, Makino, Tanaka, Poellinger (bib5) 1998; 17
Ruan, Zheng, Rong, Rong, Zhang, Fang, Zhao, Luo (bib8) 2016; 15
Bhattarai, Xu, Lee (bib2) 2018; 38
Manalo, Rowan, Lavoie, Natarajan, Kelly, Ye, Garcia, Semenza (bib7) 2005; 105
Aggarwal, Sloane (bib10) 2014; 8
Wang, Cheng, Lu, Wei, Fu, Zhu, Jia, Zhou, Xie, Zheng (bib13) 2010; 400
Epstein, Gleadle, McNeill, Hewitson, O'Rourke, Mole, Mukherji, Metzen, Wilson, Dhanda, Tian, Masson, Hamilton, Jaakkola, Barstead, Hodgkin, Maxwell, Pugh, Schofield, Ratcliffe (bib4) 2001; 107
Kos, Mitrovic, Mirkovic (bib21) 2014; 6
Lee, Bae, Jeong, Kim, Kim (bib3) 2004; 36
Li, Fang, Ao (bib12) 2016
Kaelin (bib17) 2005; 338
Ruan, Hao, Young, Zhang (bib11) 2015; 56
Helfman, Falanga (bib1) 1993; 306
Wigerup, Pahlman, Bexell (bib18) 2016; 164
Semenza (bib16) 2003; 3
Wenger, Gassmann (bib14) 1997; 378
Turk, Kos, Turk (bib20) 2004; 5
Podgorski, Sloane (bib9) 2003
Zhong, De Marzo, Laughner, Lim, Hilton, Zagzag, Buechler, Isaacs, Semenza, Simons (bib15) 1999; 59
Rankin, Giaccia (bib19) 2016; 352
Lee (10.1016/j.bbrc.2018.06.116_bib3) 2004; 36
Wang (10.1016/j.bbrc.2018.06.116_bib13) 2010; 400
Wenger (10.1016/j.bbrc.2018.06.116_bib14) 1997; 378
Ruan (10.1016/j.bbrc.2018.06.116_bib8) 2016; 15
Semenza (10.1016/j.bbrc.2018.06.116_bib16) 2003; 3
Podgorski (10.1016/j.bbrc.2018.06.116_bib9) 2003
Kallio (10.1016/j.bbrc.2018.06.116_bib5) 1998; 17
Wigerup (10.1016/j.bbrc.2018.06.116_bib18) 2016; 164
Kos (10.1016/j.bbrc.2018.06.116_bib21) 2014; 6
Epstein (10.1016/j.bbrc.2018.06.116_bib4) 2001; 107
Li (10.1016/j.bbrc.2018.06.116_bib12) 2016
Aggarwal (10.1016/j.bbrc.2018.06.116_bib10) 2014; 8
Zhong (10.1016/j.bbrc.2018.06.116_bib15) 1999; 59
Helfman (10.1016/j.bbrc.2018.06.116_bib1) 1993; 306
Krishnamachary (10.1016/j.bbrc.2018.06.116_bib6) 2003; 63
Kaelin (10.1016/j.bbrc.2018.06.116_bib17) 2005; 338
Rankin (10.1016/j.bbrc.2018.06.116_bib19) 2016; 352
Turk (10.1016/j.bbrc.2018.06.116_bib20) 2004; 5
Manalo (10.1016/j.bbrc.2018.06.116_bib7) 2005; 105
Ruan (10.1016/j.bbrc.2018.06.116_bib11) 2015; 56
Bhattarai (10.1016/j.bbrc.2018.06.116_bib2) 2018; 38
References_xml – volume: 36
  start-page: 1
  year: 2004
  end-page: 12
  ident: bib3
  article-title: Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions
  publication-title: Exp. Mol. Med.
  contributor:
    fullname: Kim
– volume: 17
  start-page: 6573
  year: 1998
  end-page: 6586
  ident: bib5
  article-title: Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha
  publication-title: EMBO J.
  contributor:
    fullname: Poellinger
– volume: 3
  start-page: 721
  year: 2003
  end-page: 732
  ident: bib16
  article-title: Targeting HIF-1 for cancer therapy
  publication-title: Nat. Rev. Canc.
  contributor:
    fullname: Semenza
– volume: 105
  start-page: 659
  year: 2005
  end-page: 669
  ident: bib7
  article-title: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
  publication-title: Blood
  contributor:
    fullname: Semenza
– volume: 400
  start-page: 587
  year: 2010
  end-page: 592
  ident: bib13
  article-title: Mitofusin-2 is a novel direct target of p53
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Zheng
– volume: 59
  start-page: 5830
  year: 1999
  end-page: 5835
  ident: bib15
  article-title: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases
  publication-title: Canc. Res.
  contributor:
    fullname: Simons
– volume: 107
  start-page: 43
  year: 2001
  end-page: 54
  ident: bib4
  article-title: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
  publication-title: Cell
  contributor:
    fullname: Ratcliffe
– volume: 15
  start-page: 17
  year: 2016
  ident: bib8
  article-title: Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
  publication-title: Mol. Canc.
  contributor:
    fullname: Luo
– volume: 338
  start-page: 627
  year: 2005
  end-page: 638
  ident: bib17
  article-title: The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing
  publication-title: Biochem. Biophys. Res. Commun.
  contributor:
    fullname: Kaelin
– volume: 164
  start-page: 152
  year: 2016
  end-page: 169
  ident: bib18
  article-title: Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
  publication-title: Pharmacol. Ther.
  contributor:
    fullname: Bexell
– volume: 306
  start-page: 37
  year: 1993
  end-page: 41
  ident: bib1
  article-title: Gene expression in low oxygen tension
  publication-title: Am. J. Med. Sci.
  contributor:
    fullname: Falanga
– volume: 352
  start-page: 175
  year: 2016
  end-page: 180
  ident: bib19
  article-title: Hypoxic control of metastasis
  publication-title: Science
  contributor:
    fullname: Giaccia
– volume: 6
  start-page: 1355
  year: 2014
  end-page: 1371
  ident: bib21
  article-title: The current stage of cathepsin B inhibitors as potential anticancer agents
  publication-title: Future Med. Chem.
  contributor:
    fullname: Mirkovic
– volume: 5
  start-page: 409
  year: 2004
  end-page: 410
  ident: bib20
  article-title: Cysteine cathepsins (proteases)–on the main stage of cancer?
  publication-title: Canc. Cell
  contributor:
    fullname: Turk
– volume: 38
  start-page: 1404
  year: 2018
  end-page: 1442
  ident: bib2
  article-title: Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): a “structure-activity relationship” perspective
  publication-title: Med. Res. Rev.
  contributor:
    fullname: Lee
– volume: 8
  start-page: 427
  year: 2014
  end-page: 437
  ident: bib10
  article-title: Cathepsin B: multiple roles in cancer
  publication-title: Proteonomics Clin. Appl.
  contributor:
    fullname: Sloane
– start-page: 263
  year: 2003
  end-page: 276
  ident: bib9
  article-title: Cathepsin B and its role(s) in cancer progression
  publication-title: Biochem. Soc. Symp.
  contributor:
    fullname: Sloane
– volume: 378
  start-page: 609
  year: 1997
  end-page: 616
  ident: bib14
  article-title: Oxygen(es) and the hypoxia-inducible factor-1
  publication-title: Biol. Chem.
  contributor:
    fullname: Gassmann
– start-page: 1
  year: 2016
  end-page: 14
  ident: bib12
  article-title: Cathepsin B and L inhibitors: a patent review (2010-present)
  publication-title: Expert Opin. Ther. Pat.
  contributor:
    fullname: Ao
– volume: 56
  start-page: 23
  year: 2015
  end-page: 40
  ident: bib11
  article-title: Targeting cathepsin B for cancer therapies
  publication-title: Horiz Cancer Res
  contributor:
    fullname: Zhang
– volume: 63
  start-page: 1138
  year: 2003
  end-page: 1143
  ident: bib6
  article-title: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1
  publication-title: Canc. Res.
  contributor:
    fullname: Semenza
– volume: 400
  start-page: 587
  year: 2010
  ident: 10.1016/j.bbrc.2018.06.116_bib13
  article-title: Mitofusin-2 is a novel direct target of p53
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2010.08.108
  contributor:
    fullname: Wang
– volume: 105
  start-page: 659
  year: 2005
  ident: 10.1016/j.bbrc.2018.06.116_bib7
  article-title: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
  publication-title: Blood
  doi: 10.1182/blood-2004-07-2958
  contributor:
    fullname: Manalo
– volume: 107
  start-page: 43
  year: 2001
  ident: 10.1016/j.bbrc.2018.06.116_bib4
  article-title: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
  publication-title: Cell
  doi: 10.1016/S0092-8674(01)00507-4
  contributor:
    fullname: Epstein
– volume: 63
  start-page: 1138
  year: 2003
  ident: 10.1016/j.bbrc.2018.06.116_bib6
  article-title: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1
  publication-title: Canc. Res.
  contributor:
    fullname: Krishnamachary
– volume: 378
  start-page: 609
  year: 1997
  ident: 10.1016/j.bbrc.2018.06.116_bib14
  article-title: Oxygen(es) and the hypoxia-inducible factor-1
  publication-title: Biol. Chem.
  contributor:
    fullname: Wenger
– volume: 338
  start-page: 627
  year: 2005
  ident: 10.1016/j.bbrc.2018.06.116_bib17
  article-title: The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2005.08.165
  contributor:
    fullname: Kaelin
– volume: 56
  start-page: 23
  year: 2015
  ident: 10.1016/j.bbrc.2018.06.116_bib11
  article-title: Targeting cathepsin B for cancer therapies
  publication-title: Horiz Cancer Res
  contributor:
    fullname: Ruan
– volume: 3
  start-page: 721
  year: 2003
  ident: 10.1016/j.bbrc.2018.06.116_bib16
  article-title: Targeting HIF-1 for cancer therapy
  publication-title: Nat. Rev. Canc.
  doi: 10.1038/nrc1187
  contributor:
    fullname: Semenza
– volume: 352
  start-page: 175
  year: 2016
  ident: 10.1016/j.bbrc.2018.06.116_bib19
  article-title: Hypoxic control of metastasis
  publication-title: Science
  doi: 10.1126/science.aaf4405
  contributor:
    fullname: Rankin
– volume: 38
  start-page: 1404
  year: 2018
  ident: 10.1016/j.bbrc.2018.06.116_bib2
  article-title: Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): a “structure-activity relationship” perspective
  publication-title: Med. Res. Rev.
  doi: 10.1002/med.21477
  contributor:
    fullname: Bhattarai
– volume: 6
  start-page: 1355
  year: 2014
  ident: 10.1016/j.bbrc.2018.06.116_bib21
  article-title: The current stage of cathepsin B inhibitors as potential anticancer agents
  publication-title: Future Med. Chem.
  doi: 10.4155/fmc.14.73
  contributor:
    fullname: Kos
– start-page: 263
  year: 2003
  ident: 10.1016/j.bbrc.2018.06.116_bib9
  article-title: Cathepsin B and its role(s) in cancer progression
  publication-title: Biochem. Soc. Symp.
  contributor:
    fullname: Podgorski
– start-page: 1
  year: 2016
  ident: 10.1016/j.bbrc.2018.06.116_bib12
  article-title: Cathepsin B and L inhibitors: a patent review (2010-present)
  publication-title: Expert Opin. Ther. Pat.
  contributor:
    fullname: Li
– volume: 17
  start-page: 6573
  year: 1998
  ident: 10.1016/j.bbrc.2018.06.116_bib5
  article-title: Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha
  publication-title: EMBO J.
  doi: 10.1093/emboj/17.22.6573
  contributor:
    fullname: Kallio
– volume: 15
  start-page: 17
  year: 2016
  ident: 10.1016/j.bbrc.2018.06.116_bib8
  article-title: Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
  publication-title: Mol. Canc.
  doi: 10.1186/s12943-016-0503-9
  contributor:
    fullname: Ruan
– volume: 36
  start-page: 1
  year: 2004
  ident: 10.1016/j.bbrc.2018.06.116_bib3
  article-title: Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions
  publication-title: Exp. Mol. Med.
  doi: 10.1038/emm.2004.1
  contributor:
    fullname: Lee
– volume: 306
  start-page: 37
  year: 1993
  ident: 10.1016/j.bbrc.2018.06.116_bib1
  article-title: Gene expression in low oxygen tension
  publication-title: Am. J. Med. Sci.
  doi: 10.1097/00000441-199307000-00010
  contributor:
    fullname: Helfman
– volume: 59
  start-page: 5830
  year: 1999
  ident: 10.1016/j.bbrc.2018.06.116_bib15
  article-title: Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases
  publication-title: Canc. Res.
  contributor:
    fullname: Zhong
– volume: 5
  start-page: 409
  year: 2004
  ident: 10.1016/j.bbrc.2018.06.116_bib20
  article-title: Cysteine cathepsins (proteases)–on the main stage of cancer?
  publication-title: Canc. Cell
  doi: 10.1016/S1535-6108(04)00117-5
  contributor:
    fullname: Turk
– volume: 8
  start-page: 427
  year: 2014
  ident: 10.1016/j.bbrc.2018.06.116_bib10
  article-title: Cathepsin B: multiple roles in cancer
  publication-title: Proteonomics Clin. Appl.
  doi: 10.1002/prca.201300105
  contributor:
    fullname: Aggarwal
– volume: 164
  start-page: 152
  year: 2016
  ident: 10.1016/j.bbrc.2018.06.116_bib18
  article-title: Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2016.04.009
  contributor:
    fullname: Wigerup
SSID ssj0011469
Score 2.410321
Snippet Hypoxia-inducible factor-1-alpha (HIF-1α) activates the transcription of many genes that code for proteins involved in angiogenesis, glucose metabolism, cell...
Highlights: • Cathepsin B (CTSB) is a novel target gene of hypoxia-inducible factor-1-alpha (HIF-1α). • CTSB mRNA and protein levels can be up-regulated in a...
SourceID osti
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1057
SubjectTerms 60 APPLIED LIFE SCIENCES
ANGIOGENESIS
Cathepsin B (CTSB)
Cathepsin B - genetics
CATHEPSINS
Cell Hypoxia
CELL PROLIFERATION
GLUCOSE
Hep G2 Cells
Humans
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Hypoxia-inducible factor-1-alpha (HIF-1α)
LUCIFERASE
MESSENGER-RNA
NEOPLASMS
Oxygen - metabolism
Promoter Regions, Genetic
Response Elements
Target gene
Transcription
Transcriptional Activation
Up-Regulation
Title Identification of cathepsin B as a novel target of hypoxia-inducible factor-1-alpha in HepG2 cells
URI https://dx.doi.org/10.1016/j.bbrc.2018.06.116
https://www.ncbi.nlm.nih.gov/pubmed/29935187
https://search.proquest.com/docview/2058507663
https://www.osti.gov/biblio/23105634
Volume 503
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VrRBcELRQtpTKSFUvKDSOH8ketyvKAmpPrbS3yN7YIqhNou4uopf-dmYcpxIScODmRJnImrFn5rPnAXCERq7KRZ4mmfVFIn2uEuuFxJGTuEEqb1JKTj6_0PMr-WWhFlswG3JhKKwy6v5epwdtHd-cRG6edHVNOb6pziZ8gYuSyoYhBNpGcyTlCLann7_OLx4uE1AZRC9YJ0QQc2f6MC9rb6mSIQ9lPDm1Pf-zfRq1uOX-7oYGc3T2HJ5FP5JN-6m-gC3X7MDutEEMfXPHjlmI7AxH5jvw-HQYPZkN_d12wfY5uj4e2rHWs1DDtVvVDTtlZsUMa9of7pr10eL0wbe7rv1ZmwSB_GZZ22vH-n49iBBD0i5D0rnrPmWMLgRWL-Hq7OPlbJ7EjgvJUqrJOkFfwhkpZGGVz3SVKdzuhbEuM5XwEsGiEUIrVQnOrUhtkVcIzxTqKatNqKz4CkZN27jXwBDJWcsl96ZCUGT8hPvUGzSYXC9taooxvB_4XHZ9YY1yiDj7XpJUSpJKmWoEKXoMahBF-dvyKFHz_5PugORGNFQTd0nBQ0hETq3SQo7h3SDPErlPrDGNazcr_AfiqDRHf2wMe72gH6aJFlwoXuT7_zmpN_CUnkKkmjqA0fp2496ia7O2h_Dowz0_jAv4FyvZ9DQ
link.rule.ids 230,315,786,790,891,4521,24144,27955,27956,45618,45712
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VW6FyQaUFulCKkRAXFDWOH8ketyvalLZ7aqW9WfbGFkFtEnV3Ef33jB2nUiXgwM1KMpE1Y8_MZ88D4BMauSpneZpkxhUJd7lIjGMcR5bjBqmcTn1y8tVcljf820IstmA25ML4sMqo-3udHrR1fHIcuXnc1bXP8U1lNqELXJS-bBhCoG0ucpqNYHt6flHOHy8TUBlEL1gmniDmzvRhXsbc-0qGNJTxpL7t-Z_t06jFLfd3NzSYo9NdeBH9SDLtp_oStmyzB_vTBjH03QP5TEJkZzgy34NnJ8NoZzb0d9sH0-founhoR1pHQg3XblU35IToFdGkaX_aW9JHi_sPvj907a9aJwjkN8va3FrS9-tBhBiSdgmSlrY7y4i_EFi9gpvTr9ezMokdF5IlF5N1gr6E1ZzxwgiXySoTuN0LbWymK-Y4gkXNmBSiYpQalpoirxCeCdRTRupQWfE1jJq2sQdAEMkZQzl1ukJQpN2EutRpNJhULk2qizF8Gfisur6whhoizn4oLxXlpaJSiSBFjkEMolBPlodCzf9PukMvN0_ja-IuffAQEnmnVkjGx_BxkKdC7nvW6Ma2mxX-A3FUmqM_NoY3vaAfp4kWnAla5G__c1IfYKe8vrpUl-fzi3fw3L8JUWviEEbr-419j27O2hzFZfwbCSb2JA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+cathepsin+B+as+a+novel+target+of+hypoxia-inducible+factor-1-alpha+in+HepG2+cells&rft.jtitle=Biochemical+and+biophysical+research+communications&rft.au=Xiaofei%2C+Cheng&rft.au=Yanqing%2C+Li&rft.au=Dongkai%2C+Zhou&rft.au=Dong%2C+Chen&rft.date=2018-09-05&rft.eissn=1090-2104&rft.volume=503&rft.issue=2&rft.spage=1057&rft_id=info:doi/10.1016%2Fj.bbrc.2018.06.116&rft_id=info%3Apmid%2F29935187&rft.externalDocID=29935187
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-291X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-291X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-291X&client=summon